J Cancer 2019; 10(4):1023-1031. doi:10.7150/jca.26472

Research Paper

The Role of Polymorphisms in Genes of PI3K/Akt Signaling Pathway on Prostate

Wei Xu1,2#, Zhihao Ni3#, Meng Zhang1, Jinbo Chen4, Li Zhang1, Song Wu5✉, Chaozhao Liang1✉

1. Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, 230000, China
2. Department of Blood Transfusion, The First Affiliated Hospital of Anhui Medical University, Hefei, 230000, China;
3. Trauma Department of Orthopedics, The Third Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230000, China;
4. Department of Urology, Xiangya Hospital, Central South University, NO.87 Xiangya Road, Changsha, Hunan, 410008, China
5. Shenzhen Following Precision Medical Institute, Shenzhen Luohu Hospital Group, Shenzhen, 518000, China
# These authors contributed equally to the work.

Abstract

Background and Objective: Increasing evidence suggested that polymorphisms in genes of PI3K/Akt pathway were closely related to prostate cancer (PCa) risk. Nevertheless, these results are controversial and inconclusive. Here, we conducted a comprehensive updated meta-analysis and systematic review to precisely illustrate the association between polymorphisms in genes of PI3K/Akt signaling pathway and PCa risk.

Materials and Methods: The gene set of PI3K/Akt pathway was referenced from the Kyoto Encyclopedia of Genes and Genomes (KEGG) website. Relevant studies were identified by the systematically researching on PubMed, Web of Science and Google Scholar databases up to October 1, 2017. The odds ratios (ORs) with a corresponding 95% confidential intervals (95%CIs) were applied to test their associations. All the analyses were conducted by using Stata 12.0 (Stata Corporation, USA).

Results: Finally, 38 articles comprising 62 case-control studies were enrolled for 13 polymorphisms in genes of PI3K/Akt pathway. However, overall results failed to present a positive association between polymorphisms in genes of PI3K/Akt pathway and PCa risk. Nevertheless, in the subgroup analysis by ethnicity, we identified that IL-6-rs1800795 polymorphism was associated with an increased risk of PCa for Caucasian individuals in dominant model (MM + MW vs. WW: OR = 1.245, 95%CI = 1.176-1.318, P < 0.001).

Conclusion: Our work suggests that polymorphisms in genes of PI3K/Akt Signaling Pathway are not risk factor for PCa. Further well-designed studies with larger samples and precise designs are demanded to corroborate our findings.

Keywords: PI3K/Akt, polymorphism, prostate cancer

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
How to cite this article:
Xu W, Ni Z, Zhang M, Chen J, Zhang L, Wu S, Liang C. The Role of Polymorphisms in Genes of PI3K/Akt Signaling Pathway on Prostate. J Cancer 2019; 10(4):1023-1031. doi:10.7150/jca.26472. Available from http://www.jcancer.org/v10p1023.htm